News
JHS CEO Chris Preti Receives 2026 Person of Influence Award
SPOKANE, Wash.-The Spokane Journal of Business named Chris Preti, CEO of Jubilant HollisterStier (JHS), as one of its 2026 People of Influence. “I’m humbled and deeply grateful to accept this award,” said Preti. “This really reflects the dedication of the entire team...
JHS Wins Greater Spokane Valley Chamber of Commerce Manufacturing Award for Operational Excellence
SPOKANE, Wash.- Jubilant HollisterStier (JHS), a leading contract pharmaceutical manufacturing company, is honored to win the Manufacturing Excellence Award for Operational Excellence from the Greater Spokane Valley Chamber of Commerce. "Operational excellence is a...
JHS Wins AWB Manufacturing Excellence Award for Operational Excellence
SPOKANE, Wash.- Jubilant HollisterStier (JHS), a leading contract pharmaceutical manufacturing company, is proud to announce that it has been awarded the 2025 Manufacturing Excellence Award for Operational Excellence by the Association of Washington Business (AWB)....
Jubilant HollisterStier LLC Launches New High-Speed, Isolator- Based Line at its Spokane Manufacturing Facility in the US
NOIDA, India & SPOKANE, Wash., Oct. 10, 2025 /PRNewswire/ -- Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specializing in sterile...
JHS Wins Greater Spokane Valley Chamber of Commerce Manufacturing Award for Operational Excellence
SPOKANE, Wash.- Jubilant HollisterStier (JHS), a leading contract pharmaceutical manufacturing company, is honored to win the Manufacturing Excellence Award for Operational Excellence from the Greater Spokane Valley Chamber of Commerce. "Operational excellence is a...
First Cohort Graduates Biomanufacturing Certification Program at Spokane Colleges
SPOKANE, Wash.-- Ten students graduated from the inaugural Essentials in Biomanufacturing Certification program on June 26, 2025, at Spokane Colleges. Jubilant HollisterStier (JHS), a contract pharmaceutical manufacturing company, partnered with Spokane Colleges to...
From KXYL: Spokane Community College Partners with Company to Train Biomanufacturing Workers
"We're not just creating jobs. We want to create careers." Spokane Community College partnered with Jubilant HollisterStier to launch a biomanufacturing training program this semester. The curriculum covers basic biomanufacturing operations. Students learn skills that...
Jubilant HollisterStier Awarded Manufacturer of the Year from the Association of Washington Business
Life Science Washington, an independent, non-profit trade association serving the life sciences industry in the state of Washington, notes Jubilant HollisterStier's win as the Association of Washington Business (AWB) 2024 Manufacturer of the Year.
Jubilant HollisterStier: Scaling Excellence in Pharma Manufacturing
Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this interview with Contract Pharma, CEO Chris Preti shares insights into the company’s ongoing...
Jubilant HollisterStier Named AWB’s 2024 Manufacturer of the Year
We are honored to announce that Jubilant HollisterStier has been named as the Association of Washington Business (AWB) 2024 Manufacturer of the Year. This premier award recognizes a Washington state manufacturer with a commitment to achieving business excellence,...
Jubilant HollisterStier Receives Zero Observations from Recent U.S. Food and Drug Administration Inspection
SPOKANE, WA. – Jubilant HollisterStier, a sterile fill-finish and injectable pharmaceutical contract manufacturing organization, announces that a United States Food and Drug Administration (USFDA) inspection, performed by the Center for Biologics Evaluation and...
Jubilant HollisterStier Celebrates the Opening of Their Third Manufacturing Line with a Ribbon Cutting Ceremony
02.09.2024, Spokane, WA – Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line and the groundbreaking of the next phase of their facility expansion. JHS President and CEO...
Ian Fuller Named Vice President of Operations at Jubilant HollisterStier Contract Manufacturing
09.14.2023, Spokane, WA: Jubilant HollisterStier Contract Manufacturing is pleased to announce the appointment of Ian Fuller as the new Vice President of Operations. With over 25 years of progressive management experience in the biotech and pharmaceutical industries,...
Exploring CMO Strategies with Chris Preti (DCAT Week)
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of discussion include operations and the strategic vision at Jubliant HollisterStier, the current...
Jubilant HollisterStier Appoints Chris Preti President
On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of pharmaceutical industry experience and has been the recent president of HollisterStier Allergy....
Jubilant HollisterStier Announces CAD 100Mn Expansion of its CMO Manufacturing Facility at Montreal, Canada and Government of Quebec Funding of CAD 25Mn through a Loan
06.30.2022, Noida, India: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, (JHS)a leading Canada-based pharmaceutical contract manufacturer,...
Jubilant HollisterStier LLC Enters into Cooperative Agreement of $149.6Mn with US Government to Expand Critical Vaccine Manufacturing Capacity
05.28.2022, Nabia, India: Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract...
Jubilant HollisterStier Receives Five CMO Leadership Awards 2022
03.16.2022, Spokane, WA & Montreal, CA: Jubilant HollisterStier LLC, a leading pharmaceutical contract manufacturer and a subsidiary of Jubilant Pharma Limited, today announced that it has received the prestigious CMO Leadership Awards 2022 in five categories -...
Jubilant HollisterStier to Host Groundbreaking Ceremony for $92 Million Expansion
11.11.2021, Noida, India: Jubilant HollisterStier LLC, a pharmaceutical contract manufacturer that is part of Jubilant Pharma Limited, announced plans to host a groundbreaking ceremony on Wednesday, November 17, 2021 at 11:00am PT at their Spokane, Washington...
Jubilant HollisterStier to Pump $76M into Montreal Facility
On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug production capacity and added new, specialized equipment to be used in production.
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN®
06.15.2021, Malvern, PA: Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has...
Jubilant HollisterStier Announces $92Mn Expansion for Sterile Injectable Manufacturing Capacity
06.03.2021, Spokane, WA: Jubilant HollisterStier, a wholly owned subsidiary of ultimate parent company Jubilant Pharmova Limited, announces $92M investment to expand sterile injectable manufacturing capacity at its site in Spokane, WA. This investment is being made...
Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact
In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a therapeutic COVID-19 treatment. This contract is one example of how JHS assisted in producing both...